Kuecept Ltd was established in 2007 and has grown into leading provider of analytical, preformulation and custom formulation screening and development services. In particular, our expertise is focused on preclinical and early-stage drug delivery and overcoming complex bioavailability barriers associated with developing low solubility and poorly permeable compounds.
By working exclusively in this field, we have developed a wealth of knowledge and expertise of enabling drug delivery technologies and formulation know-how in drug solubility and bioavailability enhancement and with over 600 projects completed to date on over 250 NCEs, are well placed to help resolve some of the most complex drug development issues.
In May 2016, Kuecept Ltd became part of the Aptuit Group and through this acquisition we can now offer a full suite of development services, from early discovery through clinical development.
Please view the rest of this website to see how we may assist with your drug's development.
working with us
Dr Mark Saunders (CEO)